1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits for the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. PLASMA THERAPY MARKET BY TYPE
5.1. Introduction
5.2. Pure Platelet-Rich Plasma
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Leukocyte-Rich PRP
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Pure Platelet-Rich Fibrin
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Leukocyte-Rich Fibrin
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
5.6. Plasma Proteins
5.6.1. Market Trends and Opportunities
5.6.2. Growth Prospects
6. PLASMA THERAPY MARKET BY SOURCE
6.1. Introduction
6.2. Autologous
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Allogenic
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
7. PLASMA THERAPY MARKET BY APPLICATION
7.1. Introduction
7.2. Orthopedic
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Chronic Infectious Diseases
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Dermatology
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Dentistry
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
7.6. Cardiac Muscle Injury
7.6.1. Market Trends and Opportunities
7.6.2. Growth Prospects
7.7. Nerve Injury
7.7.1. Market Trends and Opportunities
7.7.2. Growth Prospect
7.8. Others
7.8.1. Market Trends and Opportunities
7.8.2. Growth Prospects
8. PLASMA THERAPY MARKET BY END-USER
8.1. Introduction
8.2. Hospitals and Clinics
8.2.1. Market Trends and Opportunities
8.2.2. Growth Prospects
8.3. Pharmaceutical and Biotechnology Companies
8.3.1. Market Trends and Opportunities
8.3.2. Growth Prospects
8.4. Academic & Research Institutes
8.4.1. Market Trends and Opportunities
8.4.2. Growth Prospects
8.5. Others
8.5.1. Market Trends and Opportunities
8.5.2. Growth Prospects
9. PLASMA THERAPY MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Type
9.2.2. By Source
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.2.5.1. United States
9.2.5.1.1. Market Trends and Opportunities
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Trends and Opportunities
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Trends and Opportunities
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Type
9.3.2. By Source
9.3.3. By Application
9.3.4. By End-User
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Trends and Opportunities
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Trends and Opportunities
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Trends and Opportunities
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Type
9.4.2. By Source
9.4.3. By Application
9.4.4. By End-User
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.1.1. Market Trends and Opportunities
9.4.5.1.2. Growth Prospects
9.4.5.2. Germany
9.4.5.2.1. Market Trends and Opportunities
9.4.5.2.2. Growth Prospects
9.4.5.3. France
9.4.5.3.1. Market Trends and Opportunities
9.4.5.3.2. Growth Prospects
9.4.5.4. Italy
9.4.5.4.1. Market Trends and Opportunities
9.4.5.4.2. Growth Prospects
9.4.5.5. Spain
9.4.5.5.1. Market Trends and Opportunities
9.4.5.5.2. Growth Prospects
9.4.5.6. Others
9.4.5.6.1. Market Trends and Opportunities
9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Type
9.5.2. By Source
9.5.3. By Application
9.5.4. By End-User
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.1.1. Market Trends and Opportunities
9.5.5.1.2. Growth Prospects
9.5.5.2. UAE
9.5.5.2.1. Market Trends and Opportunities
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Trends and Opportunities
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Type
9.6.2. By Source
9.6.3. By Application
9.6.4. By End-User
9.6.5. By Country
9.6.5.1. Japan
9.6.5.1.1. Market Trends and Opportunities
9.6.5.1.2. Growth Prospects
9.6.5.2. China
9.6.5.2.1. Market Trends and Opportunities
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Trends and Opportunities
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Trends and Opportunities
9.6.5.4.2. Growth Prospects
9.6.5.5. Taiwan
9.6.5.5.1. Market Trends and Opportunities
9.6.5.5.2. Growth Prospects
9.6.5.6. Thailand
9.6.5.6.1. Market Trends and Opportunities
9.6.5.6.2. Growth Prospects
9.6.5.7. Indonesia
9.6.5.7.1. Market Trends and Opportunities
9.6.5.7.2. Growth Prospects
9.6.5.8. Others
9.6.5.8.1. Market Trends and Opportunities
9.6.5.8.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. BioLife Plasma Services
11.2. Grifols International S.A.
11.3. Biotest
11.4. CSL Ltd.
11.5. Bio Products Laboratory Ltd.
11.6. China Biologic Products Inc.
11.7. Kedrion S.p.A.
11.8. Octapharma